These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 27941760)

  • 21. Inhibition of Non-ATG Translational Events in Cells via Covalent Small Molecules Targeting RNA.
    Yang WY; Wilson HD; Velagapudi SP; Disney MD
    J Am Chem Soc; 2015 Apr; 137(16):5336-45. PubMed ID: 25825793
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Short antisense-locked nucleic acids (all-LNAs) correct alternative splicing abnormalities in myotonic dystrophy.
    Wojtkowiak-Szlachcic A; Taylor K; Stepniak-Konieczna E; Sznajder LJ; Mykowska A; Sroka J; Thornton CA; Sobczak K
    Nucleic Acids Res; 2015 Mar; 43(6):3318-31. PubMed ID: 25753670
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Single-molecule study of the CUG repeat-MBNL1 interaction and its inhibition by small molecules.
    Haghighat Jahromi A; Honda M; Zimmerman SC; Spies M
    Nucleic Acids Res; 2013 Jul; 41(13):6687-97. PubMed ID: 23661680
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Druglike Small Molecule that Targets r(CCUG) Repeats in Myotonic Dystrophy Type 2 Facilitates Degradation by RNA Quality Control Pathways.
    Wagner-Griffin S; Abe M; Benhamou RI; Angelbello AJ; Vishnu K; Chen JL; Childs-Disney JL; Disney MD
    J Med Chem; 2021 Jun; 64(12):8474-8485. PubMed ID: 34101465
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transcriptome-Wide Studies of RNA-Targeted Small Molecules Provide a Simple and Selective r(CUG)
    Gibaut QMR; Bush JA; Tong Y; Baisden JT; Taghavi A; Olafson H; Yao X; Childs-Disney JL; Wang ET; Disney MD
    ACS Cent Sci; 2023 Jul; 9(7):1342-1353. PubMed ID: 37521782
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Potent Inhibitor of Protein Sequestration by Expanded Triplet (CUG) Repeats that Shows Phenotypic Improvements in a Drosophila Model of Myotonic Dystrophy.
    Luu LM; Nguyen L; Peng S; Lee J; Lee HY; Wong CH; Hergenrother PJ; Chan HY; Zimmerman SC
    ChemMedChem; 2016 Jul; 11(13):1428-35. PubMed ID: 27245480
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expanded CUG Repeat RNA Induces Premature Senescence in Myotonic Dystrophy Model Cells.
    Hasuike Y; Mochizuki H; Nakamori M
    Front Genet; 2022; 13():865811. PubMed ID: 35401669
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral administration of erythromycin decreases RNA toxicity in myotonic dystrophy.
    Nakamori M; Taylor K; Mochizuki H; Sobczak K; Takahashi MP
    Ann Clin Transl Neurol; 2016 Jan; 3(1):42-54. PubMed ID: 26783549
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MBNL1 and CUGBP1 modify expanded CUG-induced toxicity in a Drosophila model of myotonic dystrophy type 1.
    de Haro M; Al-Ramahi I; De Gouyon B; Ukani L; Rosa A; Faustino NA; Ashizawa T; Cooper TA; Botas J
    Hum Mol Genet; 2006 Jul; 15(13):2138-45. PubMed ID: 16723374
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemical correction of pre-mRNA splicing defects associated with sequestration of muscleblind-like 1 protein by expanded r(CAG)-containing transcripts.
    Kumar A; Parkesh R; Sznajder LJ; Childs-Disney JL; Sobczak K; Disney MD
    ACS Chem Biol; 2012 Mar; 7(3):496-505. PubMed ID: 22252896
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Toxic RNA Templates the Synthesis of Its Own Fluorogenic Inhibitor by Using a Bio-orthogonal Tetrazine Ligation in Cells and Tissues.
    Angelbello AJ; Disney MD
    ACS Chem Biol; 2020 Jul; 15(7):1820-1825. PubMed ID: 32551539
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selective and Reversible Ligand Assembly on the DNA and RNA Repeat Sequences in Myotonic Dystrophy.
    Krueger SB; Lanzendorf AN; Jeon HH; Zimmerman SC
    Chembiochem; 2022 Sep; 23(17):e202200260. PubMed ID: 35790065
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gain of RNA function in pathological cases: Focus on myotonic dystrophy.
    Klein AF; Gasnier E; Furling D
    Biochimie; 2011 Nov; 93(11):2006-12. PubMed ID: 21763392
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Massively Parallel Optimization of the Linker Domain in Small Molecule Dimers Targeting a Toxic r(CUG) Repeat Expansion.
    Vezina-Dawod S; Angelbello AJ; Choudhary S; Wang KW; Yildirim I; Disney MD
    ACS Med Chem Lett; 2021 Jun; 12(6):907-914. PubMed ID: 34141068
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HnRNP H inhibits nuclear export of mRNA containing expanded CUG repeats and a distal branch point sequence.
    Kim DH; Langlois MA; Lee KB; Riggs AD; Puymirat J; Rossi JJ
    Nucleic Acids Res; 2005; 33(12):3866-74. PubMed ID: 16027111
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design of a bioactive small molecule that targets r(AUUCU) repeats in spinocerebellar ataxia 10.
    Yang WY; Gao R; Southern M; Sarkar PS; Disney MD
    Nat Commun; 2016 Jun; 7():11647. PubMed ID: 27248057
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Colocalization of muscleblind with RNA foci is separable from mis-regulation of alternative splicing in myotonic dystrophy.
    Ho TH; Savkur RS; Poulos MG; Mancini MA; Swanson MS; Cooper TA
    J Cell Sci; 2005 Jul; 118(Pt 13):2923-33. PubMed ID: 15961406
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Systemic delivery of a Peptide-linked morpholino oligonucleotide neutralizes mutant RNA toxicity in a mouse model of myotonic dystrophy.
    Leger AJ; Mosquea LM; Clayton NP; Wu IH; Weeden T; Nelson CA; Phillips L; Roberts E; Piepenhagen PA; Cheng SH; Wentworth BM
    Nucleic Acid Ther; 2013 Apr; 23(2):109-17. PubMed ID: 23308382
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Studying a Drug-like, RNA-Focused Small Molecule Library Identifies Compounds That Inhibit RNA Toxicity in Myotonic Dystrophy.
    Rzuczek SG; Southern MR; Disney MD
    ACS Chem Biol; 2015 Dec; 10(12):2706-15. PubMed ID: 26414664
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of MTMR1 expression and correlation with muscle pathological features in juvenile/adult onset myotonic dystrophy type 1 (DM1) and in myotonic dystrophy type 2 (DM2).
    Santoro M; Modoni A; Masciullo M; Gidaro T; Broccolini A; Ricci E; Tonali PA; Silvestri G
    Exp Mol Pathol; 2010 Oct; 89(2):158-68. PubMed ID: 20685272
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.